A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis - Related Studies

A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis

This study has been completed.

Study NCT00001422. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Arthritis, Psoriatic
		Psoriasis

2	Additional conditions recognized in this trial
		Arthritis

3	More general conditions related to this trial
		Bone Diseases
		Joint Diseases
		Musculoskeletal Diseases
		Skin Diseases
		Skin Diseases, Papulosquamous
		Spinal Diseases
		Spondylarthritis
		Spondylarthropathies

4	Interventions listed in this trial
		fludarabine

5	Additional drug interventions recognized in this trial
		Fludarabine monophosphate

6	More general drug interventions related to this trial
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)